Literature DB >> 26948524

TGF-β1-induced transcription factor networks in Langerhans cell development and maintenance.

X Zhang1,2,3, J Gu3, F-S Yu4,5, L Zhou1,2,6,7, Q-S Mi1,2,6,7.   

Abstract

Langerhans cells (LC) represent a specialized subset of evolutionarily conserved dendritic cells (DC) that populate stratified epithelial tissues, which are essential for the induction of skin and mucosal immunity and tolerance, including allergy. Transforming growth factor-β1 (TGF-β1) has been confirmed to be a predominant factor involved in LC development. Despite great advances in the understanding of LC ontogeny and diverse replenishment patterns, the underlying molecular mechanisms remain elusive. This review focuses on the recent discoveries in TGF-β1-mediated LC development and maintenance, with special attention to the involved transcription factors and related regulators.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TGF-β1; development; langerhans cells; transcription factors

Mesh：

Substances：

Year:  2016        PMID： 26948524      PMCID： PMC5016192          DOI： 10.1111/all.12871

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


  55 in total

1.  Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2.

Authors:  Eri Ichikawa; Shigeaki Hida; Yoshiki Omatsu; Susumu Shimoyama; Kazuhiko Takahara; Shinichi Miyagawa; Kayo Inaba; Shinsuke Taki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-02       Impact factor: 11.205

2.  Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo.

Authors:  Harmjan Kuipers; Frauke M Schnorfeil; Hans-Jörg Fehling; Helmut Bartels; Thomas Brocker
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

3.  Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg.

Authors:  Rahul Kushwah; Jing Wu; Jordan R Oliver; George Jiang; Jinyi Zhang; Katherine A Siminovitch; Jim Hu
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

Review 4.  Embryonic development of the human hematopoietic system.

Authors:  Manuela Tavian; Bruno Péault
Journal:  Int J Dev Biol       Date:  2005       Impact factor: 2.203

5.  Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3.

Authors:  Merav Yarmus; Eilon Woolf; Yael Bernstein; Ofer Fainaru; Varda Negreanu; Ditsa Levanon; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

Review 6.  Antigen presentation by Langerhans cells.

Authors:  Botond Z Igyártó; Daniel H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-12-12       Impact factor: 7.486

7.  Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.

Authors:  Barbara Platzer; Susanne Richter; Doris Kneidinger; Darina Waltenberger; Maximilian Woisetschläger; Herbert Strobl
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

8.  ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells.

Authors:  Giovanna Schiavoni; Fabrizio Mattei; Paola Borghi; Paola Sestili; Massimo Venditti; Herbert C Morse; Filippo Belardelli; Lucia Gabriele
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

9.  The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis.

Authors:  Florian Sparber; Julia M Scheffler; Nicole Amberg; Christoph H Tripp; Valeska Heib; Martin Hermann; Sonja P Zahner; Björn E Clausen; Boris Reizis; Lukas A Huber; Patrizia Stoitzner; Nikolaus Romani
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

10.  Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks.

Authors:  Michaël Chopin; Cyril Seillet; Stéphane Chevrier; Li Wu; Hongsheng Wang; Herbert C Morse; Gabrielle T Belz; Stephen L Nutt
Journal:  J Exp Med       Date:  2013-11-18       Impact factor: 14.307
View more
  7 in total

1.  Micro RNAs are required for Langerhans cell, skin- and lung-resident macrophage ontogeny.

Authors:  Yi Yao; Carly Martin; Congcong Yin; Chunyuan Guo; Zheng Dong; Li Zhou; Qing-Sheng Mi
Journal:  J Allergy Clin Immunol       Date:  2018-05-08       Impact factor: 10.793

2.  Cbfβ2 deficiency preserves Langerhans cell precursors by lack of selective TGFβ receptor signaling.

Authors:  Mari Tenno; Katsuyuki Shiroguchi; Sawako Muroi; Eiryo Kawakami; Keita Koseki; Kirill Kryukov; Tadashi Imanishi; Florent Ginhoux; Ichiro Taniuchi
Journal:  J Exp Med       Date:  2017-08-16       Impact factor: 14.307

Review 3.  Langerhans Cells-Programmed by the Epidermis.

Authors:  Kalum Clayton; Andres F Vallejo; James Davies; Sofia Sirvent; Marta E Polak
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

4.  The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression.

Authors:  Jing Zhang; Wenxue Liu; Fangqian Shen; Xiaoling Ma; Xiaorui Liu; Fuju Tian; Weihong Zeng; Xiaowei Xi; Yi Lin
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

5.  Smad2/4 Signaling Pathway Is Critical for Epidermal Langerhans Cell Repopulation Under Inflammatory Condition but Not Required for Their Homeostasis at Steady State.

Authors:  Linting Huang; Gui-Hua Li; Qian Yu; Yingping Xu; Steven Cvetkovski; Xuan Wang; Nirmal Parajuli; Imo Udo-Inyang; Daniel Kaplan; Li Zhou; Zhirong Yao; Qing-Sheng Mi
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

Review 6.  The Role of microRNAs in Organismal and Skin Aging.

Authors:  Marta Gerasymchuk; Viktoriia Cherkasova; Olga Kovalchuk; Igor Kovalchuk
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

7.  Impaired epidermal Langerhans cell maturation in TGFβ-inducible early gene 1 (TIEG1) knockout mice.

Authors:  Xilin Zhang; Yi Yao; Wei-Zen Wei; Zeng-Quan Yang; Jun Gu; Li Zhou
Journal:  Oncotarget       Date:  2017-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.